
Intensive glucose control (HbA1c <6.0%) may delay cognitive function decline (CFD) in type 2 diabetes. Analyzing data from 2977 participants in the ACCORD MIND trial, this study used causal forest and tree algorithms to identify effect modifiers of this intervention. Results highlight renal function as a significant modifier: those with preserved renal function showed modest benefits, while those with impaired function experienced accelerated CFD. Younger participants (<60 years) also benefited from intensive control. These findings emphasize the role of personalized HbA1c targets, particularly in managing diabetes-associated cognitive decline.
Like
Save
Share